Evaluating the long-term safety of the Aveir DR leadless pacemaker
Official title: Aveir Dual-Chamber Leadless Pacemaker Real-World Evidence Post-Approval Study
Run by Abbott Medical Devices · NCT05935007 · Data updated 2026-11-12
This study is testing the long-term safety of the Aveir DR leadless pacemaker in real-world patients to make sure it’s safe for use.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1805 (estimated) |
| Sponsor | Abbott Medical Devices Industry-sponsored |
| Locations | 1 site (Sylmar, California) |
| Status | Recruiting |
| Started | October 31, 2023 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | May 20, 2026 |
| Trial ID | NCT05935007 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who have been implanted with an Aveir DR leadless pacemaker and meet specific Medicare enrollment criteria.
✕Probably not a fit
Patients who have not received an Aveir DR leadless pacemaker or do not meet the Medicare enrollment criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods. It is a non-randomized, multi-center study that combines various real-world datasets from Abbott and the Center for Medicare Services to evaluate the safety of the Aveir DR device in a large patient population. The findings will fulfill the FDA's Condition of Approval requirements for the Aveir DR device by providing essential long-term safety data.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the long-term safety of the Aveir DR leadless pacemaker, potentially improving patient outcomes.
How similar studies have gone: Other studies utilizing real-world evidence methods have shown promise in evaluating medical devices, suggesting that this approach could yield valuable safety data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Eligibility Criteria: * Implanted with an Aveir DR leadless pacemaker * Continuous enrollment in Medicare Part A and Part B for 12 months prior to implant and for -30 days after implant, except in the case of death within the 30-day period * Ability to link with Medicare fee-for-service data
Where it's running
-
Abbott
Sylmar, California, United States Recruiting
Study contacts
- Study coordinator: Nicole Harbert
- Email: nicole.harbert@abbott.com
- Phone: 972-526-4841
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
BIOTRONIK CSP Lead Registry for Left Bundle Branch Area Pacing
This registry tests BIOTRONIK’s CSP-based pacing lead in patients needing a pacemaker or CRT, to see how it performs in real-life use.
-
Leadless Conduction System Pacemaker for Chronic Bradycardia
This study tests a leadless AVEIR CSP pacemaker to see if it safely and reliably keeps heart rhythm in adults who need a pacemaker.
-
Evaluating the Aveir Atrial Leadless Pacemaker for Medicare Patients
This study is testing how well the Aveir Atrial Leadless Pacemaker works and what complications it might cause for Medicare patients compared to a regular pacemaker.
-
SPIKE FLOW endocardial pacing lead safety and performance study
This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.
-
Factors Linked to Slow Heart Rate After Pulsed Field Ablation for Atrial Fibrillation
This study looks for factors that might cause bradycardia during the hospital stay after AF ablation using pulsed field technology.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.